Attached files

file filename
EX-31.1 - EX-31.1 - Cytek Biosciences, Inc.d229618dex311.htm
10-Q/A - 10-Q/A - Cytek Biosciences, Inc.d229618d10qa.htm

Exhibit 31.2

CERTIFICATION PURSUANT TO

RULES 13a-14(a) AND 15d-14(a) UNDER THE SECURITIES EXCHANGE ACT OF 1934,

AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Patrik Jeanmonod, certify that:

 

  1.

I have reviewed this Quarterly Report on Form 10-Q/A of Cytek Biosciences, Inc.; and

 

  2.

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report.

 

Date: September 8, 2021     By:   /s/ Patrik Jeanmonod
      Patrik Jeanmonod
      Chief Financial Officer
      (Principal Financial and Accounting Officer)